{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:54:49Z","timestamp":1760853289831},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1007\/s11940-001-0006-9","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T17:58:10Z","timestamp":1180979890000},"page":"249-256","source":"Crossref","is-referenced-by-count":14,"title":["Lysosomal storage diseases"],"prefix":"10.1007","volume":"3","author":[{"given":"Edward M.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"6_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, et al.: The frequency of lysosomal storage diseases in The Netherlands. Hum Genet 1999, 105:151\u2013156.","journal-title":"Hum Genet"},{"key":"6_CR2","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","volume":"324","author":"NW Barton","year":"1991","unstructured":"Barton NW, Brady RO, Dambrosia JM, et al.: Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher\u2019s disease. N Engl J Med 1991, 324:1464\u20131470.","journal-title":"N Engl J Med"},{"key":"6_CR3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/bcmd.2000.0310","volume":"26","author":"G Altarescu","year":"2000","unstructured":"Altarescu G, Schiffmann R, Parker CC, et al.: Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease. Blood Cells Mol Dis 2000, 26:285\u2013290. Excellent recent article on enzyme replacement therapy.","journal-title":"Blood Cells Mol Dis"},{"key":"6_CR4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1073\/pnas.97.1.365","volume":"97","author":"R Schiffmann","year":"2000","unstructured":"Schiffmann R, Murray GJ, Treco D, et al.: Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci U S A 2000, 97:365\u201370. This is the first paper that discusses enzyme replacement therapy in Fabry disease.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl 2","key":"6_CR5","first-page":"S38","volume":"67","author":"CM Eng","year":"2000","unstructured":"Eng CM, Cochat P, Wilcox WR, et al.: Enzyme replacement in Fabry disease: results of a placebo-controlled phase 3 trial. Amer J Hum Genet 2000, 67(suppl 2):S38.","journal-title":"Amer J Hum Genet"},{"key":"6_CR6","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","volume":"355","author":"T Cox","year":"2000","unstructured":"Cox T, Lachmann R, Hollak C, et al.: Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 2000, 355:1481\u20131485. This is the first human study that uses a glcolipid synthesis inhibitor.","journal-title":"Lancet"},{"key":"6_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/096368979500400409","volume":"4","author":"W Krivit","year":"1995","unstructured":"Krivit W, Sung JH, Shapiro EG, Lockman LA: Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. Cell Transplant 1995, 4:385\u2013392.","journal-title":"Cell Transplant"},{"key":"6_CR8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.76.2.92","volume":"76","author":"A Vellodi","year":"1997","unstructured":"Vellodi A, Young EP, Cooper A, et al.: Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centers. Arch Dis Child 1997, 76:92\u201399.","journal-title":"Arch Dis Child"},{"key":"6_CR9","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","volume":"91","author":"C Peters","year":"1998","unstructured":"Peters C, Shapiro EG, Anderson J, et al.: Hurler syndrome II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. Blood 1998, 91:2601\u20132608. Large, multicenter review that gives a broader perspective on the effectiveness of bone marrow transplantation.","journal-title":"Blood"},{"key":"6_CR10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","volume":"133","author":"N Guffon","year":"1998","unstructured":"Guffon N, Souillet G, Maire I, et al.: Follow-up of nine patients with Hurler syndrome after bone marrow transplantation. J Pediatr 1998, 133:119\u2013125.","journal-title":"J Pediatr"},{"key":"6_CR11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","volume":"22","author":"A Vellodi","year":"1999","unstructured":"Vellodi A, Young E, Cooper A, et al.: Long-term follow-up following bone marrow transplantation for Hunter disease. J Inherit Metab Dis 1999, 22:638\u2013648.","journal-title":"J Inherit Metab Dis"},{"key":"6_CR12","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","volume":"345","author":"PM Hoogerbrugge","year":"1995","unstructured":"Hoogerbrugge PM, Brouwer OF, Bordigoni P, et al.: Allogeneic bone marrow transplantaion for lysosomal storage diseases. Lancet 1995, 345:1398\u20131402.","journal-title":"Lancet"},{"key":"6_CR13","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1005526628598","volume":"22","author":"P Sivakumur","year":"1999","unstructured":"Sivakumur P, Wraith JE: Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling. J Inherit Metab Dis 1999, 22:849\u2013850.","journal-title":"J Inherit Metab Dis"},{"key":"6_CR14","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF01800232","volume":"15","author":"A Vellodi","year":"1992","unstructured":"Vellodi A, Young E, New M, et al.: Bone marrow transplantation for Sanfilippo disease type B. J Inherit Metab Dis 1992, 15:911\u2013918.","journal-title":"J Inherit Metab Dis"},{"key":"6_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00710053","volume":"18","author":"EG Shapiro","year":"1995","unstructured":"Shapiro EG, Lockman LA, Balthazor M, Krivit W: Neuropsychological outcomes of several storage diseases with and without bone marrow transplantation. J Inherit Metab Dis 1995, 18:413\u2013429.","journal-title":"J Inherit Metab Dis"},{"key":"6_CR16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1702528","volume":"26","author":"V Lee","year":"2000","unstructured":"Lee V, Li CK, Shing MM, Chik KW, et al.: Umbilical cord blood transplantation for Maroteaux-Lamy syndrome mucopolysaccharidosis type VII. Bone Marrow Transplant 2000, 26:455\u2013458.","journal-title":"Bone Marrow Transplant"},{"key":"6_CR17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1023\/A:1005447232027","volume":"22","author":"E Herskhovitz","year":"1999","unstructured":"Herskhovitz E, Young E, Rainer J, et al.: Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up. J Inherit Metab Dis 1999, 22:50\u201362.","journal-title":"J Inherit Metab Dis"},{"key":"6_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","volume":"21","author":"Y Yamada","year":"1998","unstructured":"Yamada Y, Kato K, Sukegawa K, et al.: Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation. Bone Marrow Transplant 1998, 21:629\u2013634.","journal-title":"Bone Marrow Transplant"},{"key":"6_CR19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJM199804163381605","volume":"338","author":"W Krivit","year":"1998","unstructured":"Krivit W, Shapiro EG, Peters C, et al.: Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N Engl J Med 1998, 338:1119\u20131126. This paper provides the first well documented evidence of bone marrow transplantation in Krabbe.","journal-title":"N Engl J Med"},{"key":"6_CR20","first-page":"1003","volume":"17","author":"G Malm","year":"1996","unstructured":"Malm G, Ringden O, Winiarski J, et al.: Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplant 1996, 17:1003\u20131008.","journal-title":"Bone Marrow Transplant"},{"key":"6_CR21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1702489","volume":"26","author":"AM Yeager","year":"2000","unstructured":"Yeager AM, Uhas KA, Coles CD, et al.: Bone marrow transplantation for infantile ceramidase deficiency (Farber disease) [In Process citation]. Bone Marrow Transplant 2000, 26:357\u2013363.","journal-title":"Bone Marrow Transplant"},{"key":"6_CR22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/BF01800234","volume":"15","author":"E Bayever","year":"1992","unstructured":"Bayever E, Kamani N, Ferreira P, et al.: Bone marrow transplantation for Niemann-Pick type IA disease. J Inherit Metab Dis 1992, 15:919\u2013928.","journal-title":"J Inherit Metab Dis"},{"key":"6_CR23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/bmj.295.6610.1375","volume":"295","author":"A Vellodi","year":"1987","unstructured":"Vellodi A, Hobbs JR, O\u2019Donnell NM, et al.: Treatment of Niemann-Pick disease type B by allogeneic bone marrow transplantation. Br Med J 1987, 295:1375\u20131376.","journal-title":"Br Med J"},{"key":"6_CR24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.bmt.1701826","volume":"24","author":"YS Hsu","year":"1999","unstructured":"Hsu YS, Hwu WL, Huang SF, et al.: Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation. Bone Marrow Transplant 1999, 24:103\u2013107.","journal-title":"Bone Marrow Transplant"},{"key":"6_CR25","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1136\/adc.62.10.1044","volume":"62","author":"A Will","year":"1987","unstructured":"Will A, Cooper A, Hatton C, et al.: Bone marrow transplantation in the treatment of alpha-mannosidosis. Arch Dis Child 1987, 62:1044\u20131049.","journal-title":"Arch Dis Child"},{"key":"6_CR26","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0022-3476(98)70237-9","volume":"133","author":"DA Wall","year":"1998","unstructured":"Wall DA, Grange DK, Goulding P, et al.: Bone marrow transplantation for the treatment of alpha-mannosidosis. J Pediatr 1998, 133:282\u2013285.","journal-title":"J Pediatr"},{"key":"6_CR27","first-page":"153","volume":"15","author":"A Vellodi","year":"1995","unstructured":"Vellodi A, Cragg H, Winchester B, et al.: Allogeneic bone marrow transplantation for fucosidosis. Bone Marrow Transplant 1995, 15:153\u2013158.","journal-title":"Bone Marrow Transplant"},{"key":"6_CR28","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/ajmg.1320420439","volume":"42","author":"RM Taylor","year":"1992","unstructured":"Taylor RM, Farrow BR, Stewart GJ: Amelioration of clinical disease following bone marrow transplantation in fucosidase-deficient dogs. Am J Med Genet 1992, 42:628\u2013632.","journal-title":"Am J Med Genet"},{"key":"6_CR29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/exnr.1999.7176","volume":"160","author":"AF Skorupa","year":"1999","unstructured":"Skorupa AF, Fisher KJ, Wilson JM, et al.: Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol 1999, 160:17\u201327.","journal-title":"Exp Neurol"},{"key":"6_CR30","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1182\/blood.V95.11.3631","volume":"95","author":"T Ohashi","year":"2000","unstructured":"Ohashi T, Yokoo T, Iizuka S, et al.: Reduction of lysosomal storage in murine mucopolysaccharidosis type VII by transplantation of normal and genetically modified macrophages. Blood 2000, 95:3631\u20133633.","journal-title":"Blood"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-001-0006-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-001-0006-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-001-0006-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:28:11Z","timestamp":1587580091000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-001-0006-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["6"],"URL":"https:\/\/doi.org\/10.1007\/s11940-001-0006-9","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}